FL S0564

Prohibits health insurers and health maintenance organizations from excluding coverage for cancer treatment drugs not FDA-approved if recognized in standard reference compendia or medical literature.

Prohibits insurers from requiring prior treatment failure with different drugs before covering prescriptions for stage 4 metastatic cancer and associated conditions.

Prohibits mandatory home infusion for cancer medications unless the treating oncologist determines it will not jeopardize the patient's health.

Requires insurers to publish clear prior authorization requirements and restrictions on publicly accessible websites, with 60 days' notice before implementing new or changed requirements.

Requires insurers to authorize or deny prior authorization requests within 72 hours for non-urgent care and 24 hours for urgent care situations, and notify patients and providers of decisions within those timeframes.